Events & Presentations | Zymeworks Inc.

UPCOMING EVENTS

Date	Title
06/08/2023 at 1:00 PM EDT	Jefferies Healthcare Conference Click here for webcast Add to Outlook Add to Google Calendar
06/20 - 06/21/2023	Citi's European Healthcare Conference Add to Outlook Add to Google Calendar

PAST EVENTS

Date	Title
04/10/2021	American Association for Cancer Research (AACR) Annual Meeting Supporting Materials Title: Super-resolution imaging studies of zanidatamab: providing insights into its bispecific mode of action 4.3 MB Title: The bispecific antibody zanidatamab’s (ZW25’s) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers 4.3 MB Title: ProTECT™, a novel antibody platform for integrating tumor-specific immune modulation and enhancing the therapeutic window of targeted multispecific biologics 9.3 MB Title: Increasing the therapeutic index of IL-12 by engineering for tumor-specific protease activation 2.7 MB Title: Understanding the geometry and valency of bispecific antibodies in the optimization of tumor-dependent activation of 4-1BB 5.2 MB
03/11/2021	Barclays Global Healthcare Conference
01/27/2021	ZW49 Clinical Update Conference Call Listen to webcast
01/15/2021	Zanidatamab ASCO GI Conference Call Audio Supporting Materials Presentation 15.6 MB
01/15/2021	American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Supporting Materials Title: A Phase 2b, Open-label, Single-arm Study of Zanidatamab (ZW25) Monotherapy in Patients with Advanced or Metastatic HER2-amplified Biliary Tract Cancer (BTC): HERIZON-BTC-01 Study 410.1 KB Title: Zanidatamab (ZW25) in HER2-positive Biliary Tract Cancer (BTC): Results From a Phase 1 Study 390.9 KB Title: Zanidatamab (ZW25) in HER2-expressing Gastroesophageal Adenocarcinoma (GEA): Results from a Phase 1 Study 1.8 MB
01/11/2021	JP Morgan Healthcare Conference
11/19/2020	Wolfe’s 2020 Virtual Healthcare Conference
11/18/2020	Jefferies’ Virtual London Healthcare Conference
11/17/2020	Stifel’s 2020 Virtual Healthcare Conference
09/15/2020	H.C. Wainwright 22nd Annual Global Investment Conference